Pharma stocks advance; Ipca Labs, Cadila Healthcare soar up to 19%
Given India is relatively better placed to scale up and due to lower outbreak of Covid-19, India may benefit by supplying more to US and EU, analysts say.
Given India is relatively better placed to scale up and due to lower outbreak of Covid-19, India may benefit by supplying more to US and EU, analysts say. https://ift.tt/3dh9bXC March 19, 2020 at 07:05PM
Given India is relatively better placed to scale up and due to lower outbreak of Covid-19, India may benefit by supplying more to US and EU, analysts say. https://ift.tt/3dh9bXC March 19, 2020 at 07:05PM
Comments
Post a Comment